Erasca, Inc. - stock earnings
ERAS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -30.4 million USD | ? USD |
| 2023Q2 | -31.8 million USD | ? USD |
| 2023Q1 | -29.4 million USD | ? USD |
| 2022Q4 | -132.1 million USD | ? USD |
| 2022Q3 | -34.7 million USD | ? USD |
| 2022Q2 | -35.3 million USD | ? USD |
| 2022Q1 | -36.4 million USD | ? USD |
| 2021Q4 | -30.5 million USD | ? USD |
| 2021Q3 | -46.1 million USD | ? USD |
| 2021Q2 | -28.2 million USD | ? USD |
| 2021Q1 | -18.0 million USD | ? USD |
| 2020Q4 | -61.9 million USD | ? USD |
| 2020Q3 | -10.6 million USD | ? USD |
| 2020Q2 | -5.5 million USD | ? USD |
| 2020Q1 | -23.7 million USD | ? USD |
ERAS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -230.6 million USD | ? USD |
| 2022 | -238.2 million USD | ? USD |
| 2021 | -150.1 million USD | ? USD |
| 2020 | -173.1 million USD | ? USD |
| 2019 | -10.7 million USD | ? USD |
ERAS
Price: $2.21
52 week price:
Earnings Per Share: -0.83 USD
P/E Ratio: -1.02
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 393750
Market Capitalization: 346.0 million